| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rosmantuzumab | r-spondin-3 | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
63.65 | phase 1 | unknown |
| click here to return to the previous page | ||||||||